Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 30, 2014
Event: Announcement of financial results for the three and nine months ended September 30, 2014, and details of a related conference call.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained in the press release furnished as Exhibit 99.1, which is incorporated by reference but not included in the provided text.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. Investors must refer to Exhibit 99.1 for comparative financial analysis.
Guidance, Outlook, and Risks
Management Commentary: The company announced a conference call to be held at 11:00 AM EST on October 30, 2014, to discuss the results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the periods ended September 30, 2014.
- Verify year-over-year and quarter-over-quarter growth rates in the attached press release.
- Confirm the details of the conference call held on October 30, 2014, for management's outlook and guidance.
- Check subsequent filings (e.g., 10-Q) for the audited or reviewed financial statements corresponding to this period.